ARID1A and cholangiocarcinoma: suggested the tumor-suppressive functions for ARID1A in CCA pathogenesis and further identified a total of 35 non-synonymous ARID1A somatic mutations, including 17 indels, 14 non-sense mutations, 3 missense mutations, and 1 splice-site mutation.